Mayo Clinic Platform Accelerate 推出面向 12 家临床 AI 初创公司的多年期路径
Mayo Clinic Platform Accelerate Launches Multiyear Pathway for 12 Clinical AI Startups
你需要了解的内容：
Mayo Clinic Platform
已在其 Accelerate 计划中启动了一个多年期路径项目，宣布首批 12 家健康技术公司组成的队列，这些公司专注于涵盖医疗服务提供和企业运营的人工智能。
自 2022 年启动以来，Mayo Clinic Platform Accelerate已在全球支持超过 130 家组合公司，历史上一直依托结构化的 30 周路径。
新的多年期路径扩展了该架构，为成熟期和临床阶段的 AI 公司提供持续多年访问 Mayo Clinic Platform 的安全发现环境、技术指导和去标识化纵向临床数据集的机会——该数据集涵盖数百万份多模态患者记录，包括实验室结果、临床流程表、病理学和诊断成像。
面向 12 家临床 AI 初创公司的多年期路径
首届多年期队列：涵盖 12 家构建专业临床和运营解决方案的人工智能公司：
Cappsule：
环境临床监测和持续真实世界数据采集。
CerebraAI：
作为医疗器械的软件（SaMD），将非增强 CT 扫描提升至更接近 MRI 级诊断准确性。
Clair Health：
以持续、直接激素追踪为基础的女性健康平台。
Durotimi AI：
用于精准肿瘤治疗的本地化 AI 系统。
Electrokare：
生物智能基础设施，将片段化快照转化为连续测量。
Floe Health：
为医院病例管理构建的临床推理引擎。
Koroid：
AI 原生操作系统，简化医疗运营和人员能力。
MedLink Global：
为精神科护理设计的 AI 驱动临床工具。
OPTT Health：
经临床验证、可扩展的数字心理健康护理平台。
PONS：
面向大众市场的超声诊断智能，用于疾病早期检测。
Radical Health：
面向患者的第二意见服务，提供个性化治疗建议。
Respiree：
经临床验证的机器学习，跟踪整个诊疗连续体中的心肺疾病进展。
“Accelerate 计划被特意设计用于支持已准备好变革医疗保健的数字健康公司，”Mayo Clinic Platform Accelerate 计划主任 Jamie Sundsbak 表示。“随着参与度持续增长，该计划已演进为通过针对其不同开发阶段量身定制的多种路径来支持解决方案开发者。”
What You Should Know:
Mayo Clinic Platform
has launched a multiyear pathway program within its Accelerate initiative, announcing an inaugural cohort of 12 health technology companies focused on artificial intelligence across care delivery and enterprise operations.
– Since its launch in 2022, Mayo Clinic Platform Accelerate has supported over 130 portfolio companies globally, historically leaning on structured 30-week tracks.
– The new multiyear pathway expands that architecture, providing mature and clinical-stage AI companies with sustained, multi-year access to Mayo Clinic Platform’s secure discovery environment, technical mentorship, and de-identified longitudinal clinical dataset—which spans millions of multimodal patient records including lab results, clinical flowsheets, pathology, and diagnostic imaging.
Multiyear Pathway for 12 Clinical AI Startups
The Inaugural Multiyear Cohort: Encompasses 12 artificial intelligence companies building specialized clinical and operational solutions:
Cappsule:
Ambient clinical monitoring and continuous real-world data capture.
CerebraAI:
Software as a Medical Device (SaMD) upgrading noncontrast CT scans closer to MRI-grade diagnostic accuracy.
Clair Health:
Women’s health platform grounded in continuous, direct hormone tracking.
Durotimi AI:
Localized AI systems for precision oncology care.
Electrokare:
Biological intelligence infrastructure turning episodic snapshots into continuous measurements.
Floe Health:
Clinical reasoning engine built for hospital case management.
Koroid:
AI-native operating system streamlining healthcare operations and workforce capacity.
MedLink Global:
AI-driven clinical tools designed for psychiatric care.
OPTT Health:
Clinically validated, scalable digital mental healthcare platform.
PONS:
Mass-market ultrasound diagnostic intelligence for early disease detection.
Radical Health:
Patient-facing second-opinion service delivering personalized treatment recommendations.
Respiree:
Clinically validated machine learning tracking cardiopulmonary disease progression across the continuum.
“The Accelerate program was intentionally designed to support digital health companies ready to transform healthcare,” said Jamie Sundsbak, Director of the Mayo Clinic Platform Accelerate program. “As participation continues to grow, the program has evolved to support solutions developers through multiple pathways tailored to their different stages of development.” Reader Interactions